Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cell Cycle. 2005 May;4(5):683-5. Epub 2005 May 25.

Met activation and receptor dimerization in cancer: a role for the Sema domain.

Author information

  • 1Molecular Oncology, Genentech Inc., South San Francisco, California 94080, USA. wickramasinghe.dineli@gene.com

Abstract

Ligand dependent activity of receptor tyrosine kinases is critical for modulating downstream signaling and cell proliferation. In normal cellular context, hepatocyte growth factor (HGF) regulates MET kinase activation and mediates cell proliferation, migration and motility. Recent elucidation of the MET extracellular domain suggests that the Sema domain, which bears structural similarity to other Semaphorins and Plexin family members, plays a critical role in ligand mediated receptor activation. Overexpression of MET which is observed in many cancers leads to ligand independent receptor dimerization and activation. Evidence to support a role for the Sema domain in cancer and therapeutic implications of targeting the Met Sema domain are discussed in this review.

PMID:
15846105
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Landes Bioscience
    Loading ...
    Write to the Help Desk